Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

Option Grant

22 Aug 2023 08:00

RNS Number : 9833J
finnCap Group PLC
22 August 2023
 

22 August 2023

finnCap Group plc

("finnCap", "the Company" or the "Group")

Option Grant

finnCap today announces completion of the grant of options under the finnCap Group plc Company Share Option Plan (the "Plan") to John Farrugia, CEO. 

Due to various corporate transactions and closed periods, it has not previously been possible for the Company to complete the issue of these incentive awards to Mr Farrugia as intended upon his appointment as CEO on 1 September 2022 and as described in the Group's Remuneration Committee report included in the Company's Annual Report and Accounts for the year-ended 31 March 2022.

The grant comprises a retention option over 2,000,000 shares with an exercise price of 1p per share, and an incentive option over 5,000,000 shares with an exercise price of 15p per share (together the "Options"). Due to various corporate transactions and closed periods since his appointment as CEO it has not been possible to formalise the grant until now. In the ordinary course, the Options will vest and become exercisable on 25 July 2025, subject to continuing employment. For the avoidance of doubt, vesting will not accelerate on completion of the recommended all-share merger between finnCap and Cenkos Securities plc.

The Options are also subject to malus and clawback for a period of two years following vesting. The Options will lapse, to the extent not exercised, on the day immediately preceding the tenth anniversary of the date of grant.

Following these awards, John Farrugia continues to have a beneficial interest over 1,927,669 Ordinary Shares (as set out in the Company's Opening Position Disclosure dated 4 April 2023 under Rule 8 of the Takeover Code), representing approximately 1.06% of the current total voting rights of the Company, and has options over Ordinary Shares in the Company as set out below:

Name of Scheme or Plan

Number of ordinary shares under options/awards

Grant Date

Vesting date

Normal lapse date

Exercise price (per share)

finnCap Group plc Company Share Option Plan

305,045

05/12/2018

05/12/2020

05/12/2023

£0.28

152,523

05/12/2018

05/12/2021

05/12/2023

£0.28

152,522

05/12/2018

05/12/2022

05/12/2023

£0.28

425,000

01/04/2020

09/07/2024

09/07/2027

£0.175

666,667

18/08/2020

01/04/2022

01/04/2025

£0.01

666,667

18/08/2020

01/04/2023

01/04/2026

£0.01

2,000,000

22/08/2023

25/07/2025

22/08/2033

£0.01

5,000,000

22/08/2023

25/07/2025

22/08/2033

£0.15

finnCap Group plc Enterprise Management Share Option Plan

775,000

01/04/2020

09/07/20241

09/07/2027

£0.175

1 Subject to the satisfaction of performance conditions

The Company's Ordinary Shares referred to above are finnCap Group plc ordinary shares of 1 penny each and the total number of shares in issue is 181,094,844.

Further details on this are included in the notification below, made in accordance with the requirements of the UK Market Abuse Regulation.

Contacts

 

finnCap Group plc Tel: +44 (0) 20 7220 0500

Robert Lister, Chairman investor.relations@finncap.com

Richard Snow, Chief Financial Officer

 

Grant Thornton (Nominated Adviser)  Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison/Samuel Littler

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

John Farrugia

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CEO

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

finnCap Group plc

b)

 

LEI

 

 

213800DLRUJW6JVNS533

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

GB00BGKPX309

b)

 

Nature of the transaction

 

 

(1) Grant of options over ordinary shares under the finnCap Group plc Company Share Option Plan at an exercise price of 1p per share

 

(2) Grant of options over ordinary shares under the finnCap Group plc Company Share Option plan at an exercise price of 15p per share

 

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

(1) £0.01

(1) 2,000,000

(2) £0.15

(2) 5,000,000

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

22 August 2023

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKPFAASDEFA
Date   Source Headline
8th Apr 20133:51 pmRNSHolding(s) in Company
2nd Apr 20139:55 amRNSNet Asset Value(s)
20th Mar 20134:27 pmRNS6th compulsory partial redemption of shares
19th Mar 20135:07 pmRNSNet Asset Value(s)
4th Mar 20132:38 pmRNS6th compulsory partial redemption of shares
1st Mar 20135:40 pmRNSNet Asset Value(s)
28th Feb 201312:02 pmRNSHalf Yearly Report
25th Jan 20135:13 pmRNSNet Asset Value(s)
22nd Jan 20135:26 pmRNSNet Asset Value(s)
20th Dec 20125:59 pmRNSNet Asset Value(s)
30th Nov 20125:12 pmRNSNet Asset Value(s)
26th Nov 20122:43 pmRNSCompany Update - Currency Exposure
21st Nov 20123:21 pmRNS5th compulsory partial redemption of shares
19th Nov 201211:36 amRNSNet Asset Value(s)
7th Nov 201210:04 amRNSNotice of AGM
29th Oct 201211:48 amRNSCompany Update - Currency Exposure
26th Oct 20125:12 pmRNSNet Asset Value(s)
19th Oct 20123:56 pmRNSNet Asset Value(s)
18th Oct 20124:54 pmRNSAnnual Financial Report
16th Oct 20125:21 pmRNSNotice of compulsory partial redemption of shares
28th Sep 20124:42 pmRNSNet Asset Value(s)
28th Sep 20123:38 pmRNSCompany update - Currency exposure
21st Sep 20123:54 pmRNSNet Asset Value(s)
11th Sep 20129:00 amRNSHolding(s) in Company
7th Sep 20129:12 amRNSHolding(s) in Company
3rd Sep 20124:04 pmRNSHolding(s) in Company
30th Aug 20125:25 pmRNSNet Asset Value(s)
30th Aug 20129:39 amRNSHolding(s) in Company
28th Aug 20122:27 pmRNSCompany update - Currency Exposure
28th Aug 20129:28 amRNSHoldings in Company
20th Aug 20124:54 pmRNSNet Asset Value(s)
26th Jul 20122:51 pmRNSNet Asset Value(s)
26th Jul 201210:47 amRNSCompany update - Currency Exposure
20th Jul 20124:49 pmRNSNet Asset Value(s)
17th Jul 201211:40 amRNSAcquisition of FRM
28th Jun 20123:48 pmRNSNet Asset Value(s)
28th Jun 20123:35 pmRNSCompany update - Currency Exposure
25th Jun 201211:27 amRNS4th Complulsory partial redemption of shares
20th Jun 20124:44 pmRNSNet Asset Value(s)
18th Jun 201210:15 amRNSDirector Declaration
29th May 20122:36 pmRNSCompany update - Currency exposure
25th May 20124:31 pmRNSNet Asset Value(s)
22nd May 20123:15 pmRNSNet Asset Value(s)
21st May 201211:26 amRNSAcquisition of FRM
14th May 201210:35 amRNSHolding(s) in Company
14th May 20129:28 amRNSNotice of compulsory partial redemption of shares
27th Apr 201212:12 pmRNSNet Asset Value(s)
27th Apr 201210:47 amRNSCompany update - Currency exposure
24th Apr 20124:25 pmRNSNet Asset Value(s)
30th Mar 20124:34 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.